The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot ...
FDA approves a new Depo-Provera warning on meningioma risk as Pfizer faces lawsuits alleging delayed disclosure of brain ...
The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns ...
For decades, millions of women have relied on the Depo-Provera birth control shot as a convenient form of long-term contraception. However, growing medical evidence has linked long-term Depo-Provera ...
FDA adds brain tumor warning to Depo-Provera label for Pfizer’s birth control injections after studies link the drug to meningioma risk.
If you’ve experienced serious side effects after using Depo-Provera, you are not alone. The birth control injection has been linked to a range of adverse health effects, including bone density loss, ...
Depo-Provera is an injectable form of birth control manufactured by Pfizer that contains a synthetic hormone, medroxyprogesterone acetate, which prevents pregnancy by stopping ovulation, thickening ...
The FDA approved a label update Friday for Pfizer's Depo-Provera birth control shot warning of meningioma—a brain tumor in ...
According to the Centers for Disease Control and Prevention (CDC), as of 2017, 65.3% of women between the ages of 15 and 49 in the United States use a form of birth control. Of this population, 10.4% ...
WESTWEGO, La. — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For years, ...
WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...
Decades after receiving regular injections of the hormonal contraceptive Depo-Provera, an estimated 1,300 women are now suing manufacturer Pfizer, alleging the company failed to adequately warn users ...